Henry Schein (HSIC) Competitors $69.03 +0.05 (+0.07%) Closing price 04:00 PM EasternExtended Trading$69.03 0.00 (0.00%) As of 05:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock HSIC vs. COO, IDXX, MASI, MMSI, AMN, AVNS, BRBR, NVST, WST, and OMIShould you be buying Henry Schein stock or one of its competitors? The main competitors of Henry Schein include Cooper Companies (COO), IDEXX Laboratories (IDXX), Masimo (MASI), Merit Medical Systems (MMSI), AMN Healthcare Services (AMN), Avanos Medical (AVNS), BellRing Brands (BRBR), Envista (NVST), West Pharmaceutical Services (WST), and Owens & Minor (OMI). Henry Schein vs. Its Competitors Cooper Companies IDEXX Laboratories Masimo Merit Medical Systems AMN Healthcare Services Avanos Medical BellRing Brands Envista West Pharmaceutical Services Owens & Minor Cooper Companies (NASDAQ:COO) and Henry Schein (NASDAQ:HSIC) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, profitability, valuation, analyst recommendations, media sentiment, earnings, risk and dividends. Do analysts prefer COO or HSIC? Cooper Companies presently has a consensus target price of $86.64, suggesting a potential upside of 34.15%. Henry Schein has a consensus target price of $76.67, suggesting a potential upside of 11.06%. Given Cooper Companies' stronger consensus rating and higher possible upside, equities research analysts clearly believe Cooper Companies is more favorable than Henry Schein.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cooper Companies 0 Sell rating(s) 2 Hold rating(s) 9 Buy rating(s) 1 Strong Buy rating(s) 2.92Henry Schein 0 Sell rating(s) 7 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.42 Which has higher valuation & earnings, COO or HSIC? Cooper Companies has higher earnings, but lower revenue than Henry Schein. Henry Schein is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCooper Companies$3.90B3.32$392.30M$2.0631.35Henry Schein$12.67B0.66$390M$3.1022.27 Which has more volatility & risk, COO or HSIC? Cooper Companies has a beta of 1, indicating that its stock price has a similar volatility profile to the S&P 500.Comparatively, Henry Schein has a beta of 0.81, indicating that its stock price is 19% less volatile than the S&P 500. Does the media favor COO or HSIC? In the previous week, Cooper Companies had 19 more articles in the media than Henry Schein. MarketBeat recorded 48 mentions for Cooper Companies and 29 mentions for Henry Schein. Henry Schein's average media sentiment score of 1.25 beat Cooper Companies' score of 0.76 indicating that Henry Schein is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cooper Companies 25 Very Positive mention(s) 3 Positive mention(s) 6 Neutral mention(s) 4 Negative mention(s) 0 Very Negative mention(s) Positive Henry Schein 19 Very Positive mention(s) 0 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders & institutionals have more ownership in COO or HSIC? 24.4% of Cooper Companies shares are held by institutional investors. Comparatively, 96.6% of Henry Schein shares are held by institutional investors. 2.0% of Cooper Companies shares are held by insiders. Comparatively, 1.1% of Henry Schein shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Is COO or HSIC more profitable? Cooper Companies has a net margin of 10.08% compared to Henry Schein's net margin of 3.05%. Henry Schein's return on equity of 14.36% beat Cooper Companies' return on equity.Company Net Margins Return on Equity Return on Assets Cooper Companies10.08% 9.88% 6.55% Henry Schein 3.05%14.36%5.52% SummaryCooper Companies beats Henry Schein on 12 of the 17 factors compared between the two stocks. Get Henry Schein News Delivered to You Automatically Sign up to receive the latest news and ratings for HSIC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HSIC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HSIC vs. The Competition Export to ExcelMetricHenry ScheinMED/DENTAL IndustryMedical SectorNASDAQ ExchangeMarket Cap$8.37B$15.18B$5.78B$9.80BDividend YieldN/A1.48%3.95%4.01%P/E Ratio22.2717.7322.5622.49Price / Sales0.662.43463.84113.07Price / Cash9.4116.2837.7359.36Price / Book2.053.7310.046.68Net Income$390M$472.13M$3.27B$265.59M7 Day Performance1.20%-1.14%3.17%3.42%1 Month Performance-2.03%-3.13%4.34%1.09%1 Year Performance-2.06%6.59%44.12%23.84% Henry Schein Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HSICHenry Schein4.0947 of 5 stars$69.03+0.1%$76.67+11.1%-4.4%$8.37B$12.67B22.2725,000Positive NewsAnalyst UpgradeCOOCooper Companies4.0927 of 5 stars$73.53+0.4%$96.73+31.5%-21.5%$14.70B$3.90B35.6916,000Trending NewsEarnings ReportAnalyst ForecastGap DownIDXXIDEXX Laboratories4.2603 of 5 stars$637.86-2.0%$649.44+1.8%+32.8%$51.03B$3.90B53.1111,000Positive NewsInsider TradeMASIMasimo4.4168 of 5 stars$153.93+0.0%$193.60+25.8%+22.3%$8.36B$2.09B-18.075,600Analyst RevisionMMSIMerit Medical Systems4.4792 of 5 stars$86.16+0.8%$107.00+24.2%-3.2%$5.10B$1.36B43.747,400News CoveragePositive NewsInsider TradeAnalyst RevisionAMNAMN Healthcare Services4.494 of 5 stars$19.43+2.7%$28.25+45.4%-61.6%$744.48M$2.98B-2.502,968Positive NewsAVNSAvanos Medical3.4303 of 5 stars$11.24+0.4%N/A-50.1%$521.54M$687.80M-1.122,227Positive NewsBRBRBellRing Brands4.2876 of 5 stars$38.50+0.4%$65.71+70.7%-28.4%$4.85B$2.00B22.00380NVSTEnvista3.6014 of 5 stars$20.75+0.5%$20.92+0.9%+13.6%$3.45B$2.51B64.8312,300WSTWest Pharmaceutical Services4.7271 of 5 stars$243.54-1.1%$320.71+31.7%-18.7%$17.51B$2.89B36.4610,600Positive NewsOMIOwens & Minor4.834 of 5 stars$5.46-3.8%$8.29+51.8%-68.9%$421.96M$10.70B-0.3523,200Positive NewsAnalyst Forecast Related Companies and Tools Related Companies COO Competitors IDXX Competitors MASI Competitors MMSI Competitors AMN Competitors AVNS Competitors BRBR Competitors NVST Competitors WST Competitors OMI Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HSIC) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWhat Are Some Strategies to Help Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Henry Schein, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Henry Schein With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.